Voriconazole use for endemic fungal infections

Alison Freifeld, Laurie Proia, David Andes, Larry M. Baddour, Janis Blair, Brad Spellberg, Sandra Arnold, Arnold Lentnek, L. Joseph Wheat

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

In a retrospective review of 24 patients with histoplasmosis, blastomycosis, or coccidioidomycosis treated with voriconazole (most for salvage therapy), the outcome was favorable (improved or stable) for 22 (95.8%) within 2 months of starting voriconazole and for 20 (83.3%) at the last follow-up. Prospective studies are required to determine its role in the treatment of endemic mycoses.

Original languageEnglish (US)
Pages (from-to)1648-1651
Number of pages4
JournalAntimicrobial Agents and Chemotherapy
Volume53
Issue number4
DOIs
StatePublished - Apr 1 2009

Fingerprint

Mycoses
Blastomycosis
Coccidioidomycosis
Salvage Therapy
Histoplasmosis
Prospective Studies
Voriconazole
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Freifeld, A., Proia, L., Andes, D., Baddour, L. M., Blair, J., Spellberg, B., ... Wheat, L. J. (2009). Voriconazole use for endemic fungal infections. Antimicrobial Agents and Chemotherapy, 53(4), 1648-1651. https://doi.org/10.1128/AAC.01148-07

Voriconazole use for endemic fungal infections. / Freifeld, Alison; Proia, Laurie; Andes, David; Baddour, Larry M.; Blair, Janis; Spellberg, Brad; Arnold, Sandra; Lentnek, Arnold; Wheat, L. Joseph.

In: Antimicrobial Agents and Chemotherapy, Vol. 53, No. 4, 01.04.2009, p. 1648-1651.

Research output: Contribution to journalArticle

Freifeld, A, Proia, L, Andes, D, Baddour, LM, Blair, J, Spellberg, B, Arnold, S, Lentnek, A & Wheat, LJ 2009, 'Voriconazole use for endemic fungal infections', Antimicrobial Agents and Chemotherapy, vol. 53, no. 4, pp. 1648-1651. https://doi.org/10.1128/AAC.01148-07
Freifeld A, Proia L, Andes D, Baddour LM, Blair J, Spellberg B et al. Voriconazole use for endemic fungal infections. Antimicrobial Agents and Chemotherapy. 2009 Apr 1;53(4):1648-1651. https://doi.org/10.1128/AAC.01148-07
Freifeld, Alison ; Proia, Laurie ; Andes, David ; Baddour, Larry M. ; Blair, Janis ; Spellberg, Brad ; Arnold, Sandra ; Lentnek, Arnold ; Wheat, L. Joseph. / Voriconazole use for endemic fungal infections. In: Antimicrobial Agents and Chemotherapy. 2009 ; Vol. 53, No. 4. pp. 1648-1651.
@article{f78da74756b34f06b2e112b4d23af49a,
title = "Voriconazole use for endemic fungal infections",
abstract = "In a retrospective review of 24 patients with histoplasmosis, blastomycosis, or coccidioidomycosis treated with voriconazole (most for salvage therapy), the outcome was favorable (improved or stable) for 22 (95.8{\%}) within 2 months of starting voriconazole and for 20 (83.3{\%}) at the last follow-up. Prospective studies are required to determine its role in the treatment of endemic mycoses.",
author = "Alison Freifeld and Laurie Proia and David Andes and Baddour, {Larry M.} and Janis Blair and Brad Spellberg and Sandra Arnold and Arnold Lentnek and Wheat, {L. Joseph}",
year = "2009",
month = "4",
day = "1",
doi = "10.1128/AAC.01148-07",
language = "English (US)",
volume = "53",
pages = "1648--1651",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "4",

}

TY - JOUR

T1 - Voriconazole use for endemic fungal infections

AU - Freifeld, Alison

AU - Proia, Laurie

AU - Andes, David

AU - Baddour, Larry M.

AU - Blair, Janis

AU - Spellberg, Brad

AU - Arnold, Sandra

AU - Lentnek, Arnold

AU - Wheat, L. Joseph

PY - 2009/4/1

Y1 - 2009/4/1

N2 - In a retrospective review of 24 patients with histoplasmosis, blastomycosis, or coccidioidomycosis treated with voriconazole (most for salvage therapy), the outcome was favorable (improved or stable) for 22 (95.8%) within 2 months of starting voriconazole and for 20 (83.3%) at the last follow-up. Prospective studies are required to determine its role in the treatment of endemic mycoses.

AB - In a retrospective review of 24 patients with histoplasmosis, blastomycosis, or coccidioidomycosis treated with voriconazole (most for salvage therapy), the outcome was favorable (improved or stable) for 22 (95.8%) within 2 months of starting voriconazole and for 20 (83.3%) at the last follow-up. Prospective studies are required to determine its role in the treatment of endemic mycoses.

UR - http://www.scopus.com/inward/record.url?scp=65649147960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65649147960&partnerID=8YFLogxK

U2 - 10.1128/AAC.01148-07

DO - 10.1128/AAC.01148-07

M3 - Article

VL - 53

SP - 1648

EP - 1651

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 4

ER -